Cyclophosphamide-based Conditioning
Cyclophosphamide-Based Conditioning is a conditioning regimen that employs cyclophosphamide as a core cytotoxic agent to induce immunosuppression and myeloablation prior to hematopoietic cell transplantation, distinguishing it from other regimens by its reliance on the alkylating properties of cyclophosphamide to eradicate malignant cells and prevent graft rejection.
1.1K
Publications
66.8K
Citations
6.8K
Authors
1.5K
Institutions
Publications per year
2017–2026
217
Parents
1.1K
Leo Luznik, Paul V. O’Donnell, Heather J. Symons et al. · Biology of Blood and Marrow Transplantation · 2008 · 1.9K citations · Full text
Medicine, Hematology, Oncology +16
Rainer Storb, H. Joachim Deeg, John Whitehead et al. · New England Journal of Medicine · 1986 · 1.5K citations
Medicine, Hematology, Immunology +14
1–5 of 1.1K
6.8K
34
h-index
32
h-index
30
h-index
30
h-index
26
h-index
1–5 of 6.8K
1.5K
Fred Hutch Cancer Center
Seattle, United States
54 h-index
562 publications
109.1K citations

Johns Hopkins University
Baltimore, United States
44 h-index
631 publications
82.1K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
43 h-index
415 publications
35.7K citations
Sidney Kimmel Comprehensive Cancer Center
Baltimore, United States
41 h-index
528 publications
99.6K citations
University of Washington
Seattle, United States
35 h-index
279 publications
29.5K citations

University of Minnesota
Minneapolis, United States
29 h-index
218 publications
11.1K citations

Sorbonne Université
Paris, France
28 h-index
228 publications
15.4K citations
Memorial Sloan Kettering Cancer Center
New York, United States
28 h-index
112 publications
9.5K citations
1–8 of 1.5K
86 publications · 10.9K citations
55
h-index
79 publications · 9.3K citations
55
h-index
TCT · 146 publications · 9.8K citations
49
h-index
107 publications · 4K citations
36
h-index
Repository · 108 publications · 3.8K citations
36
h-index
1–5